Medicine | Oncology
CNS Tumors | Gliomas
High-grade gliomas
Diagnosis

Home > Disciplines > Medicine > Oncology > CNS Tumors > Gliomas > High-grade gliomas > Diagnosis

Biomarkers

.

Pierscianek D, Ahmadipour Y, Oppong MD, Rauschenbach L, Kebir S, Glas M, Sure U, Jabbarli R.
Blood-Based Biomarkers in High Grade Gliomas: a Systematic Review.
Mol Neurobiol. 2019 Feb 4. doi: 10.1007/s12035-019-1509-2. [Epub ahead of print]
Source | Full text | Similar articles

Imaging

Puranik AD, Boon M, Purandare N, Rangarajan V, Gupta T, Moiyadi A, Shetty P, Sridhar E, Agrawal A, Dev I, Shah S.
Utility of FET-PET in detecting high-grade gliomas presenting with equivocal MR imaging features.
World J Nucl Med. 2019 Jul-Sep;18(3):266-272. doi: 10.4103/wjnm.WJNM_89_18.
Source . Similar articles

¹¹C-METHIONINE PET

Garcia JR, Cozar M, Baquero M, Fernández Barrionuevo JM, Jaramillo A, Rubio J, Maida G, Soler M, Riera E.
The value of ¹¹C-methionine PET in the early differentiation between tumour recurrence and radionecrosis in patients treated for a high-grade glioma and indeterminate MRI.
Rev Esp Med Nucl Imagen Mol. 2016 Aug 6. pii: S2253-654X(16)30045-2. doi: 10.1016/j.remn.2016.06.002. [Epub ahead of print] English, Spanish.
Source | Abstract | Full text | Similar articles

Lucas JT Jr, Serrano N, Kim H, Li X, Snyder SE, Hwang S, Li Y, Hua CH, Broniscer A, Merchant TE, Shulkin BL.
¹¹C-Methionine positron emission tomography delineates non-contrast enhancing tumor regions at high risk for recurrence in pediatric high-grade glioma.
J Neurooncol. 2017 Jan 11. doi: 10.1007/s11060-016-2354-z. [Epub ahead of print]
Source | Abstract | Full text | Similar articles

PET-MRI

.

Fleischmann DF, Unterrainer M, Corradini S, Rottler M, Förster S, la Fougère C, Siepmann T, Schwaiger M, Bartenstein P, Belka C, Albert NL, Niyazi M.
Report of first recurrent glioma patients examined with PET-MRI prior to re-irradiation.
PLoS One. 2019 Jul 24;14(7):e0216111. doi: 10.1371/journal.pone.0216111. eCollection 2019.
Source | Full text | Similar articles

PSMA PET/CT

.

Salas Fragomeni RA, Menke JR, Holdhoff M, Ferrigno C, Laterra JJ, Solnes LB, Javadi MS, Szabo Z, Pomper MG, Rowe SP.
Prostate-Specific Membrane Antigen-Targeted Imaging With [18F]DCFPyL in High-Grade Gliomas.
Clin Nucl Med. 2017 Oct;42(10):e433-e435. doi: 10.1097/RLU.0000000000001769.
Source | Abstract | Full text | Similar articles

Recurrent tumors

.

de Zwart PL, van Dijken BR, Holtman GA, Stormezand GN, Dierckx RA, van Laar PJ, van der Hoorn A.
Diagnostic accuracy of positron emission tomography tracers for the differentiation of tumor progression from treatment-related changes in high-grade glioma: a systematic review and meta-analysis.
J Nucl Med. 2019 Sep 20. pii: jnumed.119.233809. doi: 10.2967/jnumed.119.233809. [Epub ahead of print]
Source . Similar articles

.

Jiang S, Eberhart CG, Lim M, Heo HY, Zhang Y, Blair L, Wen Z, Holdhoff M, Lin D, Huang P, Qin H, Quinones-Hinojosa A, Weingart JD, Barker PB, Pomper MG, Laterra J, van Zijl PCM, Blakeley JO, Zhou J.
Identifying Recurrent Malignant Glioma after Treatment Using Amide Proton Transfer-Weighted MR Imaging: A Validation Study with Image-Guided Stereotactic Biopsy.
Clin Cancer Res. 2019 Jan 15;25(2):552-561. doi: 10.1158/1078-0432.CCR-18-1233. Epub 2018 Oct 26.
Source | Full text | Similar articles